These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 1979937

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
    Plooy AC, Fichtinger-Schepman AM, Schutte HH, van Dijk M, Lohman PH.
    Carcinogenesis; 1985 Apr; 6(4):561-6. PubMed ID: 4039227
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells.
    Blommaert FA, van Dijk-Knijnenburg HC, Dijt FJ, den Engelse L, Baan RA, Berends F, Fichtinger-Schepman AM.
    Biochemistry; 1995 Jul 04; 34(26):8474-80. PubMed ID: 7599137
    [Abstract] [Full Text] [Related]

  • 7. Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.
    Motzer RJ, Reed E, Perera F, Tang D, Shamkhani H, Poirier MC, Tsai WY, Parker RJ, Bosl GJ.
    Cancer; 1994 Jun 01; 73(11):2843-52. PubMed ID: 7514956
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
    Fichtinger-Schepman AM, van der Veer JL, den Hartog JH, Lohman PH, Reedijk J.
    Biochemistry; 1985 Jan 29; 24(3):707-13. PubMed ID: 4039603
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin.
    Donahue BA, Augot M, Bellon SF, Treiber DK, Toney JH, Lippard SJ, Essigmann JM.
    Biochemistry; 1990 Jun 19; 29(24):5872-80. PubMed ID: 2383564
    [Abstract] [Full Text] [Related]

  • 13. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.
    Saris CP, van de Vaart PJ, Rietbroek RC, Blommaert FA.
    Carcinogenesis; 1996 Dec 19; 17(12):2763-9. PubMed ID: 9006117
    [Abstract] [Full Text] [Related]

  • 14. Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)Cl]+.
    Bellon SF, Lippard SJ.
    Biophys Chem; 1990 Apr 19; 35(2-3):179-88. PubMed ID: 2397272
    [Abstract] [Full Text] [Related]

  • 15. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.
    Tilby MJ, Johnson C, Knox RJ, Cordell J, Roberts JJ, Dean CJ.
    Cancer Res; 1991 Jan 01; 51(1):123-9. PubMed ID: 1703029
    [Abstract] [Full Text] [Related]

  • 16. Polyclonal antibodies elicited against trans-diamminedichloroplatinum(II)-modified DNA and their application in nonradioactive hybridization experiments.
    Brabec V, Vrana O, Kiseleva VI, Poverenny AM.
    Eur J Biochem; 1991 Nov 01; 201(3):723-30. PubMed ID: 1935966
    [Abstract] [Full Text] [Related]

  • 17. The formation and persistence of carboplatin-DNA adducts in rats.
    Blommaert FA, Michael C, van Dijk-Knijnenburg HC, Schornagel JH, den Engelse L, Fichtinger-Schepman AM.
    Cancer Chemother Pharmacol; 1996 Nov 01; 38(3):273-80. PubMed ID: 8646803
    [Abstract] [Full Text] [Related]

  • 18. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
    Hospers GA, de Vries EG, Mulder NH.
    Br J Cancer; 1990 Jan 01; 61(1):79-82. PubMed ID: 2153398
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patients.
    Boffetta P, Fichtinger-Schepman AM, Weiderpass E, van Dijk-Knijnenburg HC, Stoter G, van Oosterom AT, Keizer HJ, Fosså SD, Kaldor J, Roy P.
    Anticancer Drugs; 1998 Feb 01; 9(2):125-9. PubMed ID: 9510497
    [Abstract] [Full Text] [Related]

  • 20. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
    Comess KM, Burstyn JN, Essigmann JM, Lippard SJ.
    Biochemistry; 1992 Apr 28; 31(16):3975-90. PubMed ID: 1314653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.